Tango Therapeutics (TNGX) Q2 2026 Earnings

13MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.35
-0.19
-0.02
0.14

Details

Expected EPS
-0.3137
Actual EPS
N/A
Surprise EPS
0.31
Surprise Percent
+100%

Description

Tango Therapeutics (TNGX) will report earnings of for Q2 2026 on May 13, 2026.

0 Comments

Share your thoughts